Systems chronotherapeutics

A Ballesta, PF Innominato, R Dallmann, DA Rand… - Pharmacological …, 2017 - ASPET
Chronotherapeutics aim at treating illnesses according to the endogenous biologic rhythms,
which moderate xenobiotic metabolism and cellular drug response. The molecular clocks …

Megestrol acetate for treatment of anorexia‐cachexia syndrome

VR Garcia, E López‐Briz, RC Sanchis… - Cochrane Database …, 2013 - cochranelibrary.com
Background This is an updated version of a previously published review in The Cochrane
Library (2005, Issue 2) on'Megestrol acetate for the treatment of anorexia‐cachexia …

Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies

GS Kienle, H Kiene - Integrative cancer therapies, 2010 - journals.sagepub.com
Objective. To evaluate controlled clinical studies on the efficacy and effectiveness of Viscum
album for quality of life (QoL) in cancer. Materials and methods. The authors conducted a …

Cancer-related fatigue treatment: An overview

H Mohandas, SK Jaganathan, MP Mani… - Journal of cancer …, 2017 - journals.lww.com
Cancer-related fatigue is a symptom of cancer where most patients or the general
practitioners tend to misinterpret due to the insufficient understanding or knowledge of …

Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue

KM Mustian, GR Morrow, JK Carroll… - The …, 2007 - academic.oup.com
Cancer-related fatigue (CRF) is a debilitating, multi-faceted biopsychosocial symptom
experienced by the majority of cancer survivors during and after treatment. CRF begins after …

Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research

GS Kienle, A Glockmann, M Schink, H Kiene - Journal of experimental & …, 2009 - Springer
Background Viscum album L. extracts (VAE, European mistletoe) are a widely used
medicinal plant extract in gynaecological and breast-cancer treatment. Methods Systematic …

Management of regorafenib-related toxicities: a review

SK Krishnamoorthy, V Relias… - Therapeutic …, 2015 - journals.sagepub.com
Regorafenib (Stivarga, BAY 73-4506; Bayer Pharma AG, Berlin, Germany) is an oral
multikinase inhibitor that targets the angiogenic tumor microenvironment and oncogenic …

Breast cancer and fatigue

WA Bardwell, S Ancoli-Israel - Sleep medicine clinics, 2008 - Elsevier
Fatigue is a common and disabling symptom in patients who have breast cancer and in
breast cancer survivors. A rather nebulous concept, fatigue overlaps with sleepiness and …

[HTML][HTML] Fatigue and functional impairment in early-stage non-small cell lung cancer survivors

R Hung, P Krebs, EJ Coups, MB Feinstein… - Journal of pain and …, 2011 - Elsevier
CONTEXT: Fatigue is the most common sequela among non-small cell lung cancer
(NSCLC) survivors one to six years post-treatment and is associated with functional …

Relaxation acupressure reduces persistent cancer‐related fatigue

SM Zick, S Alrawi, G Merel, B Burris… - Evidence‐Based …, 2011 - Wiley Online Library
Persistent cancer‐related fatigue (PCRF) is a symptom experienced by many cancer
survivors. Acupressure offers a potential treatment for PCRF. We investigated if acupressure …